XML 25 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statement of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Mar. 30, 2013
Mar. 31, 2012
Operating Activities:    
Net income attributable to Kadant $ 5,284 $ 7,053
Net Income Attributable to Noncontrolling Interest 36 23
Loss from discontinued operation 29 61
Income from continuing operations 5,349 7,137
Adjustments to reconcile income from continuing operations to net cash provided by (used in) operating activities:    
Depreciation and amortization 1,953 2,243
Stock-based compensation expense 1,269 1,074
Benefit for recoveries on accounts receivable (158) (319)
Gain on the sale of property, plant, and equipment (78) (10)
Other items, net (210) 305
Changes in current assets and liabilities, net of effects of acquisition:    
Accounts receivable 1,092 797
Unbilled contract costs and fees (621) (5,160)
Inventories (592) (558)
Other current assets (829) (197)
Accounts payable 83 (362)
Other current liabilities (7) (8,736)
Contributions to pension plan (270) (240)
Net cash provided by (used in) continuing operations 6,981 (4,026)
Net cash used in discontinued operation (106) (75)
Net cash provided by (used in) operating activities 6,875 (4,101)
Investing Activities:    
Purchases of property, plant, and equipment (1,178) (258)
Proceeds from sale of property, plant, and equipment 222 113
Acquisition consideration 0 (25)
Net cash used in continuing operations for investing activities (956) (170)
Financing Activities:    
Repayments of long-term obligations (4,750) (125)
Proceeds from issuance of long-term obligations 4,500 0
Purchases of Company common stock (1,334) (1,281)
Proceeds from issuance of Company common stock 337 106
Change in restricted cash 0 271
Other, net 303 122
Net cash used in continuing operations for financing activities (944) (907)
Exchange Rate Effect on Cash and Cash Equivalents from Continuing Operations (1,126) 852
Increase (Decrease) in Cash and Cash Equivalents from Continuing Operations 3,849 (4,326)
Cash and Cash Equivalents at Beginning of Period 54,553 46,950
Cash and Cash Equivalents at End of Period 58,402 42,624
Non-cash Financing Activities:    
Issuance of Company common stock 2,191 1,690
Dividends declared but unpaid $ 1,401 $ 0